Initial assessment: The FDA's review process involves evaluating data to determine if a drug is safe and effective for its intended use. The FDA has 60 days to decide whether to file an NDA for review or reject it.
Standard review: The FDA typically reviews standard NDAs within 10 months of the 60-day filing date.
Priority review: The FDA typically reviews priority NDAs within 6 months of the 60-day filing date.
LTP doesn't have a PRV i believe, so it will be, 60 days, plus, 10 months probably.
Or, pick your poison from the below
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $33.58M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.5¢ | $105.7K | 362.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 407 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |